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Abstract:	 An	 efficient	 protocol	 for	 the	 preparation	 of	 S-(1-chloro-2,2,2-trifluoroethyl)-O-ethyl	
xanthate	is	reported.	This	reagent	serves	as	a	versatile	precursor	of	highly	functionalized	gem-
difluoroalkenes	 through	 various	 inter-	 and	 intramolecular	 radical	 reactions	 and	 subsequent	
reduction	with	activated	magnesium	metal.	
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1 Introduction 
	
Over	 the	 last	 two	 decades,	 the	 proportion	 of	 useful	 fluorine	 containing	 molecules	 has	
substantially	 increased.	 It	 is	 presently	 in	 about	 a	 third	 of	 all	 compounds	 on	 the	
pharmaceutical	and	agrochemical	markets.1	Indeed,	the	ability	of	fluorine	to	deeply	alter	the	
chemical	and	physical	properties	of	organic	molecules	is	now	well	established,2	and	provides	
a	unique	and	formidable	tool	for	drug	designers.	Of	all	valuable	fluorinated	groups,	terminal	
gem-difluoro	 alkenes	 exhibit	 broad	 applicability,	 for	 they	 can	 be	 easily	 used	 and	
transformed	 into	 important	 fluorinated	 derivatives.3	 In	 addition,	 they	 have	 an	 exclusive	
isosteric	property	to	act	as	a	carbonyl	group	mimic,4	and	are	 in	some	cases	responsible	for	
the	biological	activity	of	certain	enzyme	inhibitors	and	pesticides.5	
	
To	 date,	 there	 are	 various	 methods	 to	 prepare	 terminal	 gem-difluoroalkenes.	 Several	
pathways,	such	as	the	Wittig,6	the	Horner-Wadsworth-Emmons,7	the	Julia	type	reaction8	or	
the	Julia-Kociensky	olefinations,9	start	from	ketones	or	aldehydes.	Others	rely	on	elimination	
reactions,	 such	 as	metal	 induced	 eliminations,10	 base	 induced	 elimination	 of	 sulfones11	 or	
the	 thermal	 elimination	 of	 sulfoxides	 and	 β-hydroxy	 sulfoxides.12	 Finally,	 the	 use	 of	
difluorovinyl	 metal	 derivatives,	 such	 as	 difluorovinyllithium,13	 or	 cross-coupling14	 and	 SN2’	
type	 reactions15	 can	 offer	 suitable	 and	 powerful	 alternatives.	 Most	 of	 these	 sequences	
exploit	the	presence	of	reactive	functions,	such	as	ketones	or	alkyl	halides.	However,	there	
remains	 a	 dearth	 of	 methods	 starting	 from	 much	 less	 reactive	 groups,	 such	 as	 terminal	
alkenes.	
	
2 Result and discussion 
	
A	 few	 years	 ago,	 we	 reported	 the	 synthesis	 of	 S-(1-chloro-2,2,2-trifluoroethyl)-O-ethyl	
xanthate	 1	 and	 its	 use	 in	 a	 limited	 number	 of	 radical	 addition	 reactions.16	 This	 work	 also	
involved	 the	 preparation	 and	 study	 of	 the	 acetate	 and	 benzoate	 analogues	 2	 and	 3.	
However,	 it	 seemed	 to	 us	 that	 the	 synthetic	 potential	 of	 1	 had	 remained	 largely	
underexploited.	
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Figure	1.	A	few	fluorinated	xanthates	
	
With	 the	 aim	 of	 extending	 this	 work,	 we	 considered	 using	 this	 xanthate	 as	 a	 unique	
precursor	 to	 highly	 functionalized	 α-chlorotrifluoromethyl	 derivatives,	 as	 well	 as	 to	
heterocycles	bearing	a	gem-difluorovinyl	motif	on	the	side	chain.	The	pathway	envisaged	to	
access	 these	 heterocycles	 would	 begin	 with	 simple	 radical	 additions	 of	 xanthate	 1	 onto	
olefins	bearing	an	aromatic	ring	7,	then	harness	the	ability	of	xanthates	to	promote	radical	
cyclisations	onto	aromatic	rings	to	form	bicyclic	compounds	5.17	The	desired	difluoro	alkene	
4	would	finally	be	brought	about	by	a	metal	induced	formal	elimination	of	“Cl-F”	(Scheme	1).	
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Scheme	1.	A	Route	to	difluoroalkenes	
Our	 investigations	 began	 with	 an	 optimisation	 of	 the	 synthesis	 of	 xanthate	 1	 because,	
unfortunately,	 we	 were	 unable	 to	 duplicate	 the	 earlier	 reported	 protocol.	 The	 desired	
substance	was	obtained,	but	 in	a	very	poor	yield.	Furthermore,	we	 found	that,	contrary	 to	
what	 had	 been	 previously	 stated,	 compound	 1	 is	 totally	 stable	 to	 chromatographic	
purification.	We	 therefore	 considered	 revising	 the	 experimental	 conditions	 for	 the	 whole	
sequence.		
	
We	 rapidly	 identified	 trifluoroacetic	 acid	 as	 a	much	better	 acid/solvent	 than	 the	originally	
used	 sulfuric	 acid	 in	 acetone	 (Scheme	 2).	 Indeed,	 the	 xanthate	 intermediate	 9	 could	 be	
easily	 removed	 from	 the	 medium	 by	 simple	 extraction	 with	 pentane.	 Moreover,	 pentane	
appeared	to	be	a	suitable	solvent	for	the	next	step.	While	we	were	screening	conditions	for	
the	second	step	using	PCl5	as	a	chlorinating	reagent,	we	noticed	that	the	evaporation	of	the	
solvent	 from	 crude	 mixture	 before	 purification	 was	 mainly	 responsible	 for	 the	 yield	 loss.	
Finally,	 by	 conducting	 the	 first	 reaction	 in	 trifluoroacetic	 acid	 and	 the	 second	 in	 pentane,	
followed	by	direct	purification	of	the	crude	mixture,	we	were	able	to	isolate	xanthate	1	in	a	
good	42%	overall	yield	from	commercially	available	hemiacetal	8.	This	reproducible	protocol	
is	very	straightforward	and	was	easily	scaled	up.	Alcohol	9	may	also	be	readily	acetylated	to	
give	acetate	2,	which	is	also	a	useful	xanthate	for	additions	to	alkenes.16	
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Scheme	2.	Synthesis	of	xanthates	1	and	2	
	
With	 the	 desired	 xanthate	 1	 in	 hand,	 we	 were	 able	 to	 validate	 its	 good	 reactivity	 towards	
several	 olefins,	 using	 lauroyl	 peroxide	 (DLP)	 as	 a	 thermal	 radical	 initiator.	 The	 results	 are	
displayed	 in	 Scheme	 4	 [Xa	 =	 -SC(=S)OEt].	 In	 contrast	 to	 the	moderate	 yields	 reported	 in	 the	
previous	 publication	where	1	was	mainly	 used	without	 purification,	we	 isolated	 the	 xanthate	
adducts	11a-j	 in	excellent	yields,	up	 to	99%.	A	substantial	 increase	was	 for	 instance	observed	
with	allylphosphonate,	where	the	yield	of	the	adduct	11h	was	raised	from	27%	to	77%.	As	usual,	
xanthate	 chemistry	 showed	 a	 great	 tolerance	 towards	 several	 functional	 groups	 such	 as	
ketones,	 amides,	 ethers	 or	 pyridine	 rings.	 A	 small	 excess	 of	 xanthate	 1	 was	 used	 in	 these	
additions	(typically	1.5	equiv)	but	it	could	be	easily	recovered	at	the	end	of	the	reaction.	
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Scheme	3.	Addition	of	xanthate	1	to	alkenes		
	
Xanthate	adducts	11a-g	were	next	transformed	into	their	corresponding	polycyclic	aromatic	
or	 heteroaromatic	 derivatives	 by	 subsequent	 treatment	 with	 a	 stoichiometric	 amount	 of	
lauroyl	peroxide.	The	reactions	were	performed	in	either	refluxing	ethyl	acetate	or	refluxing	
chlorobenzene,	following	literature	protocols,18	and	ultimately	produced	bicyclic	compounds	
12a-g	 in	 good	 yields	 relative	 to	 their	 complexity.	 For	 instance,	 azaindoline,	
tetrahydronaphthyridin-2-one	 and	 tetrahydroisoquinolin-1-one	 derivatives	 were	 readily	
obtained	 in	only	 two	steps	 from	easily	accessible	precursors	 (Scheme	4).	The	cyclisation	of	
compound	12f	 represents	 a	 new	 feature,	 as	 it	 is	 one	 of	 the	 very	 rare	 examples	 of	 radical	
cyclizations	leading	to	dihydronaphthyridin-2-ones	not	substituted	on	the	lactam	nitrogen.19		
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Scheme	4.	Ring-closure	onto	aromatic	and	heteroaromatic	rings	
	
For	 compounds	 11h-j,	 we	 proceeded	 to	 the	 simple	 reductive	 removal	 of	 the	 xanthate	
moiety,	 by	 using	 either	 the	 hypophosphorous	 salt	 of	 triethylamine20	 or	
tris(trimethylsilyl)silane21	as	the	hydrogen	atom	donor	(Scheme	5).	
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Scheme	5.	Reductive	dexanthylations	of	adducts	11h-j	
	
More	 synthetically	 interesting	 is	 the	 conversion	of	β-chlorotrifluoromethyl	 derivatives	 into	
1,1-difluoroalkenes	 using	 dissolving	 metal	 reductions.	 Such	 transformations	 are	 already	
known;	 however,	 only	 bromides22	 or	 activated	 chlorides23	 have	 been	 employed	 in	 this	
reaction.	In	our	case,	the	issue	was	to	induce	the	insertion	of	a	metal	into	the	un-activated	
carbon-chloride	 bond	 to	 promote	 the	 elimination.	 Taking	 compound	 12a	 as	 a	 model	
substrate,	 we	 screened	 several	 experimental	 conditions.	 The	 first	 promising	 result	 was	
obtained	by	treatment	with	zinc	flakes	in	refluxing	ethyl	acetate	(Table	1,	entry	3)	so	that	we	
were	 able	 to	 isolate	 the	 desired	 compound	 in	 a	 quantitative	 yield.	 Unfortunately,	 this	
reaction	 proved	 non-reproducible	 and	 forced	 us	 to	 examine	 other	 more	 reducing	 metals	
such	as	lithium	and	magnesium.	Promising	results	were	obtained	with	tert-butyl	lithium	but,	
to	our	dismay,	it	again	turned	out	to	be	unreliable.	Finally,	magnesium,	activated	in	situ	by	a	
sub-stoichiometric	 amount	 of	 1,2-dibromoethane,	 promoted	 the	 elimination	 efficiently.	
After	a	few	trials,	we	concluded	that	the	periodic	addition	of	1,2-dibromoethane	permitted	
a	quantitative	conversion	systematically.	The	optimized	protocol	is	easy	to	implement,	and	a	
standard	work-up	yields	the	desired	1,1-difluoroalkene	essentially	quantitatively.	
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1 Zn,a CuI cat. DMF 20-50°C 0%
2 Zn,b CuI cat. DMF 20-50°C 0%
5 i-PrMgCl THF 0 °C -rt 0%
6 i-PrMgCl, LiCl THF 0 °C -rt 0%
3 Zna AcOEt reflux      0-100%c
4 Zna EtCO2H reflux     8%c
7 n-BuLi THF –78 °C -rt 0%
8 t-BuLi THF –78 °C -rt 40-75%c
9 Mg MeOH reflux, 2h     0-30%c
10 Mg MeOH reflux, 24h     0-30%c
11 Mg, I2 MeOH reflux 0%
12 THF reflux 0-5%
13 Mg EtOH reflux 0%
14 Mg CF3CH2OH reflux 0%
15
Mg, Br(CH2)2Br THF reflux 50-85%
Mg MeOH/PhMe reflux 0%
16
17 Mg, Br(CH2)2Brd THF reflux 100%
a) zinc flakes; b) zinc powder; c) reactions not reproducible; 
d) periodic addition of 1,2-dibromoethane during the reaction.
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Table	1.	Optimisation	trials	for	the	reductive	elimination	
	
We	were	further	pleased	to	find	that	the	same	conditions	were	equally	efficient	for	most	of	
the	other	derivatives	 (Scheme	6).	Compound	14f	 and	14j	were	obtained	 in	only	50%	yield,	
because	 of	 the	 competing	 cleavage	 of	 the	 amide	 functions.	 Indeed,	 in	 the	 case	 of	 14j,	
besides	 the	 desired	 product,	 diphenylamine	 resulting	 from	 the	 cleavage	of	 the	 amide	was	
isolated	in	33%	yield.	
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Scheme	6.	Synthesis	of	difluoroalkenes	
	
As	far	as	compound	14d	and	14e	are	concerned,	we	assumed	that	the	degradation	observed	
came	from	the	hydrolytic	instability	of	the	acetyl	moiety.	We	therefore	proceeded	with	the	
quantitative	removal	of	the	acetyl	protecting	group	by	treatment	with	potassium	carbonate	
in	methanol	and	subjected	the	naked	substrates	15a	and	15b	to	the	elimination	conditions.	
To	our	delight,	the	desired	terminal	gem-difluoroalkenes	16a	and	16b	were	formed	in	very	
good	yield	(Scheme	7).	
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Scheme	7.	Synthesis	of	azaindolines	and	tetrahydroazaquinolines	
	
In	 a	 further	 variation,	 we	 found	 that	 xanthate	 1	 is	 able	 to	 undergo	 a	 radical	 allylation	
reaction	we	 recently	 developed.	 It	 involves	 the	 use	 of	 2-fluoropyridyl	 derivatives	 of	 allylic	
alcohols	 as	 the	 allylating	 agents	 and	 overcomes	 the	 activation	 barrier	 resulting	 from	 the	
strong	 and	 difficult	 to	 homolyze	 carbon-oxygen	 bond.24	 As	 depicted	 in	 Scheme	 8,	 the	
reaction	of	xanthate	1	with	substrate	17	gave	the	desired	product	in	a	good	75%	yield.	The	
β-chlorotrifluoromethyl	derivative	18,	bearing	a	double	bond	at	the	δ	position	and	a	masked	
aldehyde,	would	be	very	tedious	to	make	by	more	conventional	methods.	Interestingly,	base	
induced	elimination	of	HCl	from	compound	18	would	lead	in	principle	to	the	formation	of	a	
trifluoromethyl-substituted	diene.	
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Scheme	8.	Radical	allylation	of	xanthate	1	
	3 Conclusion 
	
In	 conclusion,	 we	 now	 have	 in	 hand	 a	 unified,	 flexible,	 and	 convergent	 strategy	 for	 the	
synthesis	 of	 various	 acyclic	 and	heterocyclic	 substances	bearing	 a	 terminal	 difluoro	 alkene	
side	 chain.	 The	methodology	 is	 based	 on	 the	 use	 of	 S-1-chloro-2,2,2-trifluoroethyl-O-ethyl	
xanthate	1	 as	a	 fluorinated	precursor,	 the	synthesis	of	which	has	been	 re-examined	and	 is	
now	easily	reproducible	and	scalable.	Reagent	1	represents	 in	fact	the	synthetic	equivalent	
of	 a	 2,2-difluorovinyl	 radical	 (F2C=CH•),	 which	 is	 too	 reactive	 to	 undergo	 cleanly	
intermolecular	additions	to	un-activated	alkenes.	
	
4 Experimental 
	
4.1 General Experimental Methods  
	
Purification	procedures	were	in	accordance	with	the	instructions	in	D.	D.	Perrin	and	W.	L.	F.	
Armarego,	 “Purification	 of	 Laboratory	 Chemicals”,	 Fourth	 Edition,	 The	 Bath	 Press,	 Bath,	
2002.	All	reactions	were	carried	out	under	dry,	oxygen	free	nitrogen.	Flash	chromatography	
was	performed	on	silica	gel	(SDS,	60	Å	C.	C.	40-63	mm)	as	the	stationary	phase.	Thin	Layer	
Chromatography	 (TLC)	was	 performed	on	 alumina	 plates	 pre-coated	with	 silica	 gel	 (Merck	
silica	 gel,	 60	 F254),	 which	 were	 visualized	 by	 the	 quenching	 of	 UV	 fluorescence	 when	
applicable	(λmax	=	254	nm	and/or	366	nm)	and/or	by	staining	with	vanillin	or	anisadehyde	
in	acidic	ethanol	followed	by	heating.		Infrared	spectra	were	recorded	as	solutions	in	CH2Cl2	
using	 NaCl	 cells,	 on	 a	 Perkin-Elmer	 FT	 2000.	 Absorption	 maxima	 (nmax)	 are	 reported	 in	
wavenumbers	 (cm−1)	 and	 only	 selected	 peaks	 are	 reported.	 Magnetic	 resonance	 spectra	
were	 recorded	 at	 room	 temperature	 on	 a	 Bruker	 Avance	 DPX	 400	 instrument.	 Proton	
magnetic	resonance	spectra	(1H	NMR)	were	recorded	at	400	MHz	and	coupling	constants	(J)	
are	reported	to	±	0.5	Hz.	The	following	abbreviations	were	utilized	to	describe	peak	patterns	
when	 appropriate:	 br	 =	 broad,	 s	 =	 singlet,	 d	 =	 doublet,	 t	 =	 triplet,	 q	 =	 quartet,	 quint	 =	
quintuplet,	 hex	 =	 hexuplet,	 hept	 =	 heptuplet,	 oct	 =	 octuplet	 and	 m	 =	 multiplet.	 	 Carbon	
magnetic	resonance	spectra	(13C	NMR)	were	recorded	in	the	same	instrument	at	100.6	MHz.	
Chemical	shifts	(δH,	δC)	are	quoted	in	parts	per	million	(ppm)	and	are	referenced	to	TMS	(0	
ppm).	Low-resolution	mass	spectra	(m/z)	were	recorded	by	chemical	 ionization	(CI/NH3)	on	
a	 Hewlett-Packard	 HP	 5989B	 and	 only	 report	 molecular	 species	 ([M+H]+,	 [M+NH4]+)	 and	
other	 major	 fragments.	 High-resolution	 mass	 spectra	 were	 recorded	 by	 positive	 electron	
impact	 ionization	(EI+)	at	70	e.V.	on	a	JEOL	JMS-GCmate	 II	mass	spectrometer.	The	quoted	
masses	are	accurate	 to	±	5	ppm.	The	names	of	 the	molecules	 that	appear	 in	 the	 following	
pages	 were	 generated	 using	 either	 Beilstein	 AutoNom	 2000	 (CAS)	 or	 ChemBioDraw	 Ultra	
11.0	
	
4.2 General procedures 
4.2.1 General	procedure	A	for	the	addition	reaction	
A	solution	of	olefin	(n	mmol)	and	xanthate	(between	1.3	n	and	2	n	mmol)	in	AcOEt	(n	mL)	was	
refluxed	 under	 a	 flow	 of	 nitrogen	 for	 15	 minutes.	 Lauroyl	 peroxide	 (DLP)	 5	 mol%	 was	 then	
added	every	hour	until	 total	 conversion	of	 the	 starting	olefin	was	observed.	The	mixture	was	
cooled	to	room	temperature	and	the	solvent	evaporated	under	reduced	pressure.	Flash	column	
chromatography	afforded	the	desired	adduct	as	a	mixture	of	two	diastereoisomers.	
4.2.2 General	procedure	B	for	the	cyclisation	reaction	
A	 solution	of	 the	 xanthate	 adduct	 (n	mmol)	 in	 either	AcOEt	 or	 chlorobenzene	 (50	n	mL)	was	
refluxed	 under	 a	 flow	 of	 nitrogen	 for	 15	minutes.	 Lauroyl	 peroxide	 (DLP)	 20	mol%	was	 then	
added	every	15min	(chlorobenzene)	or	every	hour	(ethyl	acetate)	until	total	conversion	of	the	
starting	 olefin	 was	 observed.	 The	mixture	 was	 cooled	 to	 room	 temperature	 and	 the	 solvent	
evaporated	 under	 reduced	 pressure.	 Flash	 column	 chromatography	 afforded	 the	 desired	
product	as	a	mixture	of	two	diastereoisomers.	
4.2.3 General procedure C for the elimination reaction 
A	 magnetically	 round	 bottom	 flask	 was	 charged	 with	 the	 corresponding	 trifluorochloro	
compound	(n	mmol),	freshly	activated	magnesium	(20	n	mmol),	and	dry	THF	(33	n	mL)	and	the	
suspension	was	 heated	 up	 to	 reflux.	 1,2-Dibromoethane	 (0.5	 n	mmol)	was	 then	 added	 every	
two	hours	until	total	conversion	of	the	starting	material	was	observed	by	NMR.	The	mixture	was	
cooled	to	room	temperature	and	a	saturated	solution	of	citric	acid	(15	n	mL)	was	added.	After	
total	disappearance	of	solid	magnesium,	Et2O	was	added,	 the	 layers	were	partitioned	and	the	
aqueous	 one	was	 extracted	 twice	with	 Et2O.	 The	 combined	organic	 layers	were	washed	with	
brine	 and	 dried	 over	 anhydrous	MgSO4.	 Removal	 of	 the	 solvent	 and	 flash	 chromatography	 if	
necessary	yielded	to	the	desired	difluoro	olefin.	
	
4.3 Experimental Procedures and Spectroscopic Data 
4.3.1 [(1-Chloro-2,2,2-trifluoroethyl)sulfanyl](ethoxy)methanethione	 (1) 
A	magnetically	stirred	round	bottom	flask	was	charged	with	potassium	ethyl	xanthate	salt	(8	g,	
50	mmol),	100	mL	of	trifluoroacetic	acid	and	cooled	to	0	°C.	2,2,2-Trifluoro-1-methoxyethan-1-ol	
(8.19	g,	63	mmol)	was	added	slowly	and	the	solution	was	stirred	30	min	at	0	°C	and	1	hour	at	
room	 temperature.	 Pentane	 (100	 mL)	 and	 water	 (100	 mL)	 were	 added,	 the	 layers	 were	
separated	 and	 the	 aqueous	 layer	was	 extracted	 twice	with	 pentane	 (100	mL).	 The	 combined	
organic	 layers	 were	 washed	 with	 brine	 and	 dried	 over	 anhydrous	 MgSO4.	 The	 solution	 was	
concentrated	to	100	mL	in	vacuo,	was	cooled	to	0	°C	and	phosphorus	pentachloride	(13.10	g,	63	
mmol)	was	added.	The	solution	was	stirred	at	0	°C	for	30	minutes	and	at	room	temperature	for	
2	hours.	The	solution	was	then	directly	purified	by	silica	gel	column	chromatography25	(pentane	
100%)	and	 concentrated	under	 reduced	pressure	at	 20	 °C	 to	 afford	1	 (5.01	 g,	 42%)	 as	 a	pale	
yellow	liquid.	1H	NMR	(400	MHz;	CDCl3):	δH	6.26	(q,	J	=	6.9	Hz,	1H),	4.74	(q,	J	=	7.1	Hz,	2H),	1.47	
(t,	J	=	7.1	Hz);	13C	NMR	(100	MHz;	CDCl3):	δC	206.4,	122.7	(q,	J	=	279	Hz),	72.0,	63.6	(q,	J	=	37	Hz),	
13.6.	The	spectral	data	were	incorrectly	reported	in	the	original	communication	(ref.	16).	
4.3.2 1-(Ethoxycarbonothioylthio)-2,2,2-trifluoroethyl acetate (2) 
A	magnetically	stirred	round	bottom	flask	was	charged	with	potassium	ethyl	xanthate	salt	(0.8	g,	
5	mmol),	10	mL	of	 trifluoroacetic	acid	and	cooled	to	0	 °C.	2,2,2-trifluoro-1-methoxyethan-1-ol	
(0.72	ml,	7.5	mmol)	was	added	slowly	and	the	solution	was	stirred	30	min	at	0	°C	and	1	hour	at	
room	 temperature.	 Acetic	 anhydride	 (0.47	mL,	 5	mmol)	 and	 pyridine	 (0.4	mL,	 5	mmol)	were	
then	 added	 drop-wise	 and	 the	 solution	was	 stirred	 30	min.	 DCM	 (30	mL)	 and	water	 (30	mL)	
were	added,	 the	 layers	were	separated	and	the	aqueous	 layer	was	extracted	twice	with	DCM	
(30	mL).	The	combined	organic	layers	were	washed	with	HCl	(1%),	water,	brine,	and	dried	over	
anhydrous	MgSO4.	The	 solution	was	concentrated	 in	vacuo	 (cold	bath	water)	and	 the	 residue	
was	 purified	 by	 silica	 gel	 column	 chromatography	 (petroleum	 ether	 /	 ethyl	 acetate	 98:2)	 to	
afford	2	(1.2	g,	90%)	as	a	yellow	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	7.19	(q,	J	=	6.8	Hz,	1H),	4.69	
(dq,	J	=	7.2,	1.6	Hz,	2H),	2.18	(s,	3H),	1.44	(t,	J	=	7.2	Hz,	3H);	13C	NMR	(100	MHz;	CDCl3):	δC	205.7,	
167.6,	122.4	(q,	J	=	278	Hz),	76.5	(q,	J	=	36	Hz),	71.4,	20.3,	13.5;	IR	(CCl4):	νmax 2987,	1780,	1443,	
1371,	1345,	1231,	1131,	1112,	1030.	The	spectral	data	were	incorrectly	reported	in	the	original	
communication	(ref.	16).	
4.3.3 N-{4-Chloro-2-[(ethoxymethanethioyl)sulfanyl]-5,5,5-trifluoropentyl}-N-phenylmethanesulfonamide
	 (11a) 
Following	 general	 procedure	 A,	 the	 reaction	 was	 carried	 out	 using	N-phenyl-N-(prop-2-en-1-
yl)methanesulfonamide26	 (1.27	 g,	 6.0	mmol),	 xanthate	 1	 (1.86	 g,	 7.8	mmol).	 The	 residue	was	
purified	by	 silica	 gel	 column	chromatography	 (petroleum	ether/ethyl	 acetate	80:20)	 to	 afford	
the	corresponding	xanthate	adduct	11a	 (2592	mg,	96%)	as	a	mixture	of	 two	diastereoisomers	
80:20	and	as	a	colorless	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	7.50-7.35	(m,	5H),	4.60-4.51		(m,	2H),	
4.47-4.39	(m,	0.2H),	4.39-4.29	(m,	0.8H),	4.10-4.00	(m,	1.2H),	3.98-3.82	(m,	1.8H),	2.90	(s,	2.4H),	
2.89	(s,	0.6H),	2.75	(ddd,	J	=	15.1,	6.9,	5.3	Hz,	0.2H),	2.56	(ddd,	J	=	14.7,	11.9,	2.6	Hz,	0.8H),	2.19	
(ddd,	J	=	15.3,	11.9,	2.1	Hz,	0.8H),	2.19-2.12	(m,	0.2H),	1.34	(t,	J	=	7.1	Hz,	0.6H),	1.32	(t,	J	=	7.1	
Hz,	2.4H);	13C	NMR	(100	MHz;	CDCl3):	δC	major	diastereoisomer:	210.5,	137.9,	129.7	(2C),	128.9	
(2C),	128.8,	123.8	(q,	J	=	279	Hz),	70.6,	54.9	(d,	J	=	33.7	Hz),	53.6,	44.9,	37.1,	31.4,	13.6;	minor	
diastereoisomer:	211.0,	138.3,	129.7,	128.9,	128.7,	123.8	(q,	J	=	279	Hz),	70.4,	54.4	(q,	J	=	33	Hz),	
52.76,	 45.9,	 37.0,	 33.1,	 13.6;	 IR	 (CCl4):	 νmax	2987,	 1493,	 1357,	 1267,	 1225,	 1185,	 1161,	 1132,	
1052;	HRMS	(EI+):	calculated	(found)	for	C12H1035ClF3NO2	:	328.0386	(328.0390).	
	
4.3.4 5-Chloro-3-[(ethoxymethanethioyl)sulfanyl]-6,6,6-trifluoro-N-(6-methylpyridin-2-yl)hexanamide
	 (11b) 
Following	general	procedure	A,	the	reaction	was	carried	out	using	N-(6-methylpyridin-2-yl)but-
3-enamide	(500	mg,	2.83	mmol),	xanthate	1	(1.0	g,	4.5mmol).	The	residue	was	purified	by	silica	
gel	 column	 chromatography	 (petroleum	 ether/ethyl	 acetate	 85:15)	 to	 afford	 the	 xanthate	
adduct	11b	(850	mg,	72%)	as	a	mixture	of	two	diastereoisomers	60:40	and	as	a	colorless	oil.	1H	
NMR	(400	MHz;	CDCl3):	δH	9.25	(bs,	0.4H),	9.11	(bs,	0.6H),	8.04-7.88	(m,	1H),	7.56	(t,	J	=	7.8	Hz,	
1H),	6.87	(d,	J	=	7.4	Hz,	1H),	4.66-4.52	(m,	2H),	4.48-4.29	(m,	2H),	3.04-2.80	(m,	2H),	2.71-2.52	
(m,	1H),	2.39	(s,	3H),	2.35-2.20	(m,	1H),	1.41-1.33	(m,	3H);	13C	NMR	(100	MHz;	CDCl3):	δC	major	
diastereoisomer:	211.7,	168.0,	156.5,	150.3,	138.7,	123.7	(q,	J	=	279	Hz),	119.5,	111.3,	70.4,	55.3	
(q,	 J	 =	 33	Hz),	 43.5,	41.8,	34.6,	23.7,	13.5;	minor	diastereoisomer:	211.6,	168.0,	156.5,	150.2,	
138.7,	123.7	(q,	J	=	279	Hz),	119.6,	111.4,	70.3,	54.8	(q,	J	=	33	Hz),	43.1,	39.2,	34.4,	23.7,	13.5;	IR	
(CCl4):	νmax 3419,	2928,	1702,	1456,	1267,	1230,	1128,	1051;	HRMS	(EI+):	calculated	(found)	for	
C15H1835ClF3N2O2S2	:	414.0450	(414.0448)	
4.3.5 Ethyl	 ({4-chloro-5,5,5-trifluoro-1-[1-(4-methoxyphenyl)-N-methylformamido]pentan-2-
yl}sulfanyl)carbothioate	 (11c) 
Following	general	procedure	A,	the	reaction	was	carried	out	with	4-methoxy-N-methyl-N-(prop-
2-en-1-yl)benzamide27	 (609	 mg,	 3.0	 mmol),	 xanthate	 1	 (928	 mg,	 3.9mmol).	 The	 residue	 was	
purified	by	silica	gel	column	chromatography	(petroleum	ether/diether	ether	80:20	to	20:80)	to	
afford	the	xanthate	adduct	11c	(620	mg,	47%)	as	a	mixture	of	two	diastereoisomers	65:35	and	
as	a	colorless	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	7.36	(d,	J	=	8.6	Hz,	2H),	6.90	(d,	J	=	8.7	Hz,	2H),	
4.71-4.58	(m,	2.35H),	4.53-4.12	(m,	2H),	3.90-3.75	(m,	4H),	3.57-3.39	(m,	0.65H),	3.12	(s,	1.95H),	
3.09	 (s,	 1.05H),	 2.53-2.08	 (m,	 2H),	 1.44-1.39	 (m,	 3H);	 13C	 NMR	 (100	 MHz;	 CDCl3):	 δC	 major	
diastereoisomer:	211.6,	172.1,	160.7,	128.9	(2C),	127.8,	123.7	(q,	J	=	279	Hz),	113.7	(2C),	70.7,	
55.3,	55.7-54.2(m),	50.5,	45.3,	38.4,	32.4,	13;	minor	diastereoisomer:	211.8,	171.9,	160.8,	128.9	
(2C),	127.6,	123.6	(q,	279	Hz),	113.7	(	2C),	70.5,	55.3,	55.7-54.2	(m),	49.5,	45.9,	39.5,	34.1,	13.6;	
IR	 (CCl4):	νmax 2933,	1642,	1610,	1483,	1393,	1303,	1252,	1223,	1173,	1130,	1052;	HRMS	(EI+):	
calculated	(found)	for	C14H1635ClF3NO2	:	322.0822	(322.0832).	
4.3.6 N-{4-Chloro-2-[(ethoxymethanethioyl)sulfanyl]-5,5,5-trifluoropentyl}-N-(6-fluoropyridin-2-yl)acetamide
	 (11d) 
Following	 general	 procedure	 A,	 the	 reaction	 was	 carried	 out	 with	N-(6-fluoropyridin-2-yl)-N-
(prop-2-en-1-yl)acetamide28	 (2.00	 g,	 10.3	mmol),	 xanthate	 1	 (4.17	 g,	 17.5mmol).	 The	 residue	
was	 purified	 by	 silica	 gel	 column	 chromatography	 (petroleum	 ether/ethyl	 acetate	 75:25)	 to	
afford	the	xanthate	adduct	11d	(3.86	mg,	84%)	as	a	mixture	of	two	diastereoisomers	60:40	and	
as	a	yellow	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	major	diastereoisomer:	7.93	(m,	1H),	7.24-7.15	(m,	
1H),	6.99-6.93	(m,	1H),	4.66-4.55	(m,	2H),	4.49	(dd,	J	=	13.7,	8.5	Hz,	1H),	4.43-4.35	(m,	1H),	4.22-
4.06	(m,	1H),	4.03	(dd,	J	=	13.7,	6.2	Hz,	1H),	2.31	(dd,	J	=	8.4,	5.9	Hz,	2H),	2.12	(s,	3H),	1.40	(t,	J	=	
7.1	Hz,	3H);	minor	diastereoisomer:	7.93	(m,	1H),	7.24-7.15	(m,	1H),	6.99-6.93	(m,	1H),	4.66-4.55	
(m,	3H),	4.28	(dd,	J	=	6.1,	4.6	Hz,	2H),	4.22-4.06	(m,	1H),	2.53	(ddd,	J	=	14.8,	8.7,	4.1	Hz,	1H),	2.23	
(ddd,	J	=	15.1,	9.8,	5.5	Hz,	1H),	2.11	(s,	3H),	1.41	(t,	J	=	7.1	Hz,	3H);	13C	NMR	(100	MHz;	CDCl3):	δC	
major	diastereoisomer:	211.1,	170.6,	162.5	(d,	J	=	244	Hz),	152.8	(d,	J	=	13	Hz),	143.0	(d,	J	=	7	
Hz),	123.8	(q,	J	=	279	Hz),	118.8	(d,	J	=	5	Hz),	108.2	(d,	J	=	36	Hz),	70.5,	55.2	(q,	J	=	33	Hz),	49.9,	
45.9,	32.3,	23.0,	13.6;	minor	diastereoisomer:	211.3,	170.8,	162.4	(d,	J	=	244	Hz),	152.9	(d,	J	=	13	
Hz),	143.0	(d,	J	=	7	Hz),	123.9	(q,	J	=	279	Hz),	118.8	(d,	J	=	5	Hz),	108.2	(d,	J	=	36	Hz),	70.4,	54.6	(q,	
J	=	33	Hz),	48.4,	46.3,	33.9,	23.0,	13.6;	IR	(CCl4):	νmax 2928,	1684,	1600,	1452,	1378,	1311,	1267,	
1226,	1131,	1049;	HRMS	(EI+):	calculated	(found)	for	C12H1235ClF4N2O	:	311.0574	(311.0576).	
4.3.7 N-{5-chloro-3-[(ethoxymethanethioyl)sulfanyl]-6,6,6-trifluorohexyl}-N-(6-fluoropyridin-2-yl)acetamide
	 (11e) 
Following	 general	 procedure	 A,	 the	 reaction	 was	 carried	 out	 with	 N-(but-3-en-1-yl)-N-(6-
fluoropyridin-2-yl)acetamide29	 (370	 g,	 1.78mmol),	 xanthate	1	 (550	 g,	 2.31mmol).	 The	 residue	
was	 purified	 by	 silica	 gel	 column	 chromatography	 (petroleum	 ether/ethyl	 acetate	 80:20	 to	
60:40)	to	afford	the	xanthate	adduct	11e	 (740	mg,	93%)	as	a	mixture	of	two	diastereoisomers	
60:40	and	as	a	colorless	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	7.87-7.77	(m,	1H),	7.25-7.11	(m,	1H),	
6.87-6.76	(m,	1H),	4.60	(q,	J	=	6.8	Hz,	2H),	4.47-4.37	(m,	0.45H),	4.33	(dqd,	J	=	11.0,	6.6,	2.3	Hz,	
0.55H),	4.05-3.77	(m,	3H),	2.38-2.20	(m,	2H),	2.19-2.08	(m,	2H),	2.07	(s,	1.35H),	2.06	(s,	1.65H),	
1.38	(t,	J	=	7.1	Hz,	3H);	13C	NMR	(100	MHz;	CDCl3):	δC	major	diastereoisomer:	211.7,	170.1,	162.2	
(d,	J	=	243	Hz),	153.2	(d,	J	=	13.3	Hz),	142.7	(d,	J	=	7.7	Hz),	123.8	(q,	J	=	279	Hz),	117.7	(d,	J	=	5	
Hz),	 107.3	 (d,	 J	 =	 36	 Hz),	 70.4,	 55.1	 (q,	 J	 =	 33	 Hz),	 45.2,	 45.1,	 35.4,	 33.9,	 23.2,	 13.5;	 minor	
diastereoisomer:	211.6,	170.2,	162.1	(d,	J	=	243	Hz),	153.2	(d,	J	=	13.3	Hz),	142.8	(d,	J	=	7.7	Hz),	
123.8	(q,	J	=	279	Hz),	117.4	(d,	J	=	5	Hz),	107.2	(d,	J	=	36	Hz),	70.2,	54.4	(q,	J	=	33	Hz),	45.2,	44.2,	
35.4,	 30.0,	 23.2,	 13.5;	 IR	 (CCl4):	 νmax 2985,	 1682,	 1600,	 1453,	 1376,	 1268,	 1224,	 1130,	 1050;	
HRMS	(EI+):	calculated	(found)	for	C16H1935ClF4N2O2S2	:	446.0513	(446.0514).	
4.3.8 5-Chloro-N-(2,4-dichlorophenyl)-3-[(ethoxymethanethioyl)sulfanyl]-6,6,6-trifluorohexanamide
	 (11f) 
Following	general	procedure	A,	the	reaction	was	carried	out	with	N-(2,4-dichlorophenyl)but-3-
enamide30	 (690	mg,	 3.0	mmol),	 xanthate	1	 (928	mg,	 3.9	mmol).	 The	 residue	was	 purified	 by	
silica	gel	column	chromatography	(petroleum	ether/ethyl	acetate	90:10	to	60:40)	to	afford	the	
xanthate	adduct	11f	(1.37	g,	98%)	as	a	mixture	of	two	diastereoisomers	65:35	and	as	a	yellow	
oil.	1H	NMR	(400	MHz;	CDCl3):	δH	8.33	(bs,	0.35H),	8.25	(bs,	0.65H),	7.40-7.36	(m,	2H),	7.06	(s,	
1H),	4.68-4.58	(m,	2H),	4.45-4.32	(m,	2H),	3.01	(dd,	J	=	15.7,	5.2	Hz,	0.65H),	2.89	(dd,	J	=	15.7,	7.5	
Hz,	1.35H),	2.61	(ddd,	J	=	14.7,	8.9,	3.7	Hz,	0.35H),	2.53	(ddd,	J	=	13.7,	11.6,	1.9	Hz,	0.65H),	2.35	
(ddd,	J	=	15.1,	10.3,	5.4	Hz,	0.35H),	2.24	(ddd,	J	=	14.9,	11.6,	3.2	Hz,	0.65H),	1.45-1.36	(m,	3H);	
13C	NMR	 (100	MHz;	 CDCl3):	 δC	major	 diastereoisomer:	 212.0,	 168.4,	 138.8,	 135.1	 (2C),	 124.7,	
123.7	 (q,	 J	 =	 279	 Hz),	 118.5	 (2C),	 70.9,	 55.1	 (q,	 J	 =	 33	 Hz),	 43.7,	 42.3,	 34.8,	 13.6;	 minor	
diastereoisomer:	211.8,	168.4,	138.7,	135.1	(2C),	124.7,	123.7	(q,	J	=	279	Hz),	118.6	(2C),	70.7,	
54.7	 (q,	 J	 =	 33	Hz),	 43.3,	 39.9,	 34.9,	 13.6;	 IR	 (CCl4):	νmax 3434,	 2987,	 1709,	 1586,	 1518,	 1444,	
1406,	1268,	1228,	1129,	1050;	HRMS	(EI+):	calculated	(found)	for	C15H1535Cl3F3NO2S2	:	466.9562	
(466.9557).	
4.3.9 6-Chloro-4-[(ethoxymethanethioyl)sulfanyl]-7,7,7-trifluoro-1-(4-methoxyphenyl)heptan-1-one
	 (11g) 
Following	general	procedure	A,	the	reaction	was	carried	out	using	1-(4-methoxyphenyl)pent-4-
en-1-one	(380	mg,	2.0	mmol),	xanthate	1	(619	mg,	2.6	mmol).	The	residue	was	purified	by	silica	
gel	column	chromatography	(petroleum	ether/ethyl	acetate	90:10)	to	afford	the	corresponding	
xanthate	 adduct	 11g	 (850	 mg,	 99%)	 as	 a	 mixture	 of	 two	 diastereoisomers	 60:40	 and	 as	 a	
colorless	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	7.99	(d,	J	=	8.9	Hz,	2H),	6.99	(d,	J	=	8.9	Hz,	2H),	4.76-
4.57	(m,	2H),	4.50-4.40	(m,	1H),	4.23-4.14	(m,	0.6H),	4.14-4.06	(m,	0.4H),	3.92	(s,	3H),	3.29-3.10	
(m,	2H),	2.47-2.09	(m,	3.6H),	1.96	(ddt,	J	=	14.0,	10.4,	6.7	Hz,	0.4H),	1.49-1.41	(m,	3H);	13C	NMR	
(100	MHz;	CDCl3):	δC	major	diastereoisomer:	212.0,	197.1,	163.6,	130.3	(2C),	129.8,	124.0	(q,	J	=	
279	 Hz),	 113.8	 (2C),	 70.5,	 55.5,	 55.4	 (q,	 J	 =	 33	 Hz),	 47.4,	 36.3,	 35.1,	 30.0,	 13.6;	 minor	
diastereoisomer:	211.9,	197.05,	163.68,	130.3	(2C),	129.7,	124.0	(q,	J	=	279	Hz),	113.8	(2C),	70.3,	
55.5,	54.7	(q,	J	=	33	Hz),	46.6,	36.8,	35.0,	26.1,	13.6;	IR	(CCl4):	νmax 2937,	1682,	1602,	1510,	1263,	
1223,	 1170,	 1127,	 1052;	 HRMS	 (EI+):	 calculated	 (found)	 for	 C17H2035ClF3O3S2	 :	 428.0494	
(428.0504).	
4.3.10 N,N-Diphenylundec-10-enamide	 (10j) 
A	magnetically	round	bottom	flask	was	charged	with	N-phenylaniline	(13.50	g,	80	mmol),	undec-
10-enoyl	chloride	(4.04	g,	20	mmol),	and	20	mL	of	toluene	and	the	solution	was	heated	up	to	
reflux.	After	3	hours,	37%	HCl	solution	(6.7	mL,	80	mmol)	was	added	slowly,	the	salts	filtered	off	
and	 the	 solvent	 evaporated	 under	 reduced	 pressure.	 The	 residue	 was	 recrystallized	 from	
petroleum	ether	to	afford	the	desired	olefin	10j	 (6.7	g,	100%)	as	white	crystals.	Mp:	51	°C.	1H	
NMR	(400	MHz;	CDCl3):	δH	7.44-7.30	(m,	4H),	7.29-7.18	(m,	6H),	5.80	(ddt,	J	=	16.9,	10.2,	6.7	Hz,	
1H),	4.98	(dd,	J	=	17.1,	1.7	Hz,	1H),	4.92	(d,	J	=	10.2,	1H),	2.25	(t,	J	=	7.5	Hz,	2H),	2.02	(m,	2H),	
1.64	(m,	2H),	1.44-1.17	(m,	10H);	13C	NMR	(100	MHz;	CDCl3):	δC	172.8,	142.6	(2C),	138.6,	129.7-
124.8	 (10C),	 113.8,	 37.9,	 33.4,	 28.9,	 28.9,	 28.8,	 28.6,	 28.5,	 25.13;	 IR	 (CCl4):	 νmax 2928,	 2856,	
1679,	 1493,	 1370,	 1274;	 HRMS	 (EI+):	 calculated	 (found)	 for	 C15H1835ClF3O2S2:	 335.2249	
(335.2249).	
4.3.11 Dimethyl	4-chloro-2-[(ethoxymethanethioyl)sulfanyl]-5,5,5-trifluoropentane-1-phosphonate	 (11h) 
Following	 general	 procedure	 A,	 the	 reaction	 was	 carried	 out	 using	 dimethyl	 (prop-2-en-1-
yl)phosphonate	 (150	mg,	1	mmol),	xanthate	1	 (476	mg,	2	mmol).	The	residue	was	purified	by	
silica	 gel	 column	 chromatography	 (petroleum	 ether/ethyl	 acetate	 30:70)	 to	 afford	 the	
corresponding	xanthate	adduct	11h	(300	mg,	77%)	as	a	mixture	of	two	diastereoisomers	65:35	
and	as	a	pale	yellow	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	4.72-4.61	(m,	2H),	4.48-4.18	(m,	2H),	3.83-
3.74	(m,	6H),	2.69	(ddd,	J	=	14.8,	8.7,	4.1	Hz,	0.35H),	2.59-2.46	(m,	1.3H),	2.41-2.21	(m,	2.35H),	
1.44	 (t,	 J	 =	 7.1	 Hz,	 1.95H),	 1.43	 (t,	 J	 =	 7.1	 Hz,	 1.05H);	 13C	 NMR	 (100	MHz;	 CDCl3):	 δC	 major	
diastereoisomer:	211.0,	123.8	(q,	J	=	279	Hz),	70.5,	55.2	(q,	J	=	34	Hz),	52.8-52.6	(m,	2C),	42.1	(d,	
J	=	2	Hz),	34.6,	31.5	(d,	 J	=	137	Hz),	13.7;	minor	diastereoisomer:	211.5,	123.9	(q,	 J	=	279	Hz),	
70.4,	54.8	(q,	J	=	34	Hz),	52.8-52.6	(m,	2C),	41.4	(d,	J	=	4	Hz),	35.3	(d,	J	=	3	Hz),	28.9	(d,	J	=	141	
Hz),	 13.7;	 IR	 (CCl4):	 νmax 2954,	 1269,	 1227,	 1127,	 1048;	 HRMS	 (EI+):	 calculated	 (found)	 for	
C10H1735ClF3O4PS2	:	387.9946	(Found:	387.9950).	
4.3.12 Ethyl	{[4-chloro-5,5,5-trifluoro-1-(4-methoxyphenoxy)pentan-2-yl]sulfanyl}methanethioate	 (11i) 
Following	 general	 procedure	A,	 the	 reaction	was	 carried	out	using	1-methoxy-4-(prop-2-en-1-
yloxy)benzene	(164	mg,	1.0	mmol),	xanthate	1	(357	mg,	1.5	mmol).	The	residue	was	purified	by	
silica	gel	column	chromatography	 (petroleum	ether/diethyl	ether	98:2)	 to	afford	 the	xanthate	
adduct	11i	(358	mg,	89%)	as	a	mixture	of	two	diastereoisomers	60:40	and	as	a	colorless	oil.	1H	
NMR	(400	MHz;	CDCl3):	δH	6.90-6.80	(m,	4H),	4.68	(q,	 J	=	7.1	Hz,	2H),	4.50-4.32	(m,	2H),	4.29-
4.24	(m,	1H),	4.18-4.07	(m,	1H),	3.78	(s,	3H),	2.71	(ddd,	J	=	13.5,	9.7,	3.6	Hz,	0.4H),	2.47-2.40	(m,	
1H),	2.35	(ddd,	J	=	14.6,	10.7,	5.2	Hz,	0.6H),	1.44	(t,	J	=	7.1	Hz,	3H);	13C	NMR	(100	MHz;	CDCl3):	
δC	major	diastereoisomer:	211.5,	154.3,	152.1,	123.9	(q,	J	=	278	Hz),	115.7	(2C),	114.5	(2C),	70.6,	
70.4,	55.7-54.3	(m,	2C),	46.5,	32.4,	13.5;	minor	diastereoisomer:	211.8,	154.4,	152.0,	123.8	(q,	J	
=	278	Hz),	115.6	 (2C),	114.5	 (2C),	70.5,	69.9,	55.7-54.3	 (m,	2C),	45.8,	32.8,	13.5;	 IR	 (CCl4):	νmax 
2935,	1508,	1267,	1228,	1183,	1130,	1049;	HRMS	(EI+):	calculated	(found)	for	C15H1835ClF3O2S2	:	
402.0338	(402.0349).	
4.3.13 12-Chloro-10-[(ethoxymethanethioyl)sulfanyl]-13,13,13-trifluoro-N,N-diphenyltridecanamide	(11j) 
Following	 general	 procedure	 A,	 the	 reaction	 was	 carried	 out	 using	 N,N-diphenylundec-10-
enamide	(1.10	g,	3.3	mmol),	xanthate	1	(1.19	g,	5.0mmol).	The	residue	was	purified	by	silica	gel	
column	chromatography	 (petroleum	ether/diethyl	 ether	80:20)	 to	 afford	 the	 xanthate	 adduct	
11j	(1768	mg,	92%)	as	a	mixture	of	two	diastereoisomers	55/45	and	as	a	yellow	oil.	1H	NMR	(400	
MHz;	CDCl3):	δH	7.45-7.30	 (m,	4H),	7.30-7.14	 (m,	6H),	4.72-4.59	 (m,	2H),	4.42-4.32	 (m,	0.55H),	
4.27-4.18	(m,	0.45H),	4.06-3.93	(m,	1H),	2.37-2.29	(m,	1H),	2.29-2.22	(m,	2H),	2.22-2.06	(m,	1H),	
1.83-1.51	 (m,	4H),	 1.51-1.35	 (m,	5H),	 1.35-1.17	 (m,	8H);	 13C	NMR	 (100	MHz;	CDCl3):	 δC	major	
diastereoisomer:	 212.5,	 173.2,	 142.9	 (2C),	 130.3-125.4	 (m,	 10C),	 123.9	 (q,	 J	 =	 279	Hz),	 70.24,	
55.5	 (q,	 J	 =	 33	 Hz),	 47.4,	 35.7,	 35.2,	 31.5,	 29.3-28.9	 (m,	 4C),	 26.5,	 25.4,	 13.7;	 minor	
diastereoisomer:	212.5,	173.2,	142.9	(2C),	130.3-125.4	(m,	10C),	123.9	(q,	J	=	279	Hz),	70.0,	54.6	
(q,	J	=	33	Hz),	46.7,	35.9,	35.7,	35.2,	29.3-28.9	(m,	4C),	26.3,	25.4,	13.7;	IR	(CCl4):	νmax 2928,	2856,	
1680,	 1493,	 1370,	 1267,	 1220,	 1052;	 HRMS	 (EI+):	 calculated	 (found)	 for	 C25H3035ClF3NO	 :	
452.1968	(452.1968).	
4.3.14 3-(2-Chloro-3,3,3-trifluoropropyl)-1-methanesulfonyl-2,3-dihydro-1H-indole	 (12a) 
A	 solution	 of	 xanthate	 adduct	 11a	 (5.76	mmol)	 in	DCE	 (30	mL)	was	 refluxed	 under	 a	 flow	of	
nitrogen	for	15	minutes.	Lauroyl	peroxide	(DLP)	(756	mg,	33	mol%)	was	then	added	every	hour	
until	 total	 conversion	 of	 the	 starting	 olefin	 was	 observed.	 The	 mixture	 was	 cooled	 to	 room	
temperature	 and	 the	 solvent	 evaporated	 under	 reduced	 pressure.	 Recrystallization	 using	
petroleum	ether	and	AcOEt	afforded	the	desired	compound	12a	(950	mg,	48%)	as	a	mixture	of	
two	diastereoisomers	65:35	and	as	white	crystals.	 1H	NMR	(400	MHz;	CDCl3):	δH	7.47-7.39	(m,	
1H),	 7.33-7.19	 (m,	 2H),	 7.12-7.06	 (m,	 1H),	 4.21-4.12	 (m,	 1H),	 4.12-4.02	 (m,	 1H),	 3.82	 (dd,	 J	 =	
10.3,	3.4	Hz,	0.65H),	3.79-3.72	(m,	0.35H),	3.71-3.65	(m,	0.65H),	3.65-3.57	(m,	0.35H),	2.91	(s,	
3H),	 2.37-2.07	 (m,	 2H);	 13C	 NMR	 (100	 MHz;	 CDCl3):	 δC	 major	 diastereoisomer:	 141.6,	 131.9,	
129.3,	123.9	(q,	J	=	279	Hz),	124.9,	123.7,	113.7,	56.7,	55.6	(q,	J	=	34	Hz),	36.6,	35.6,	34.3;	minor	
diastereoisomer:	141.6,	132.7,	129.0,	123.8	(q,	J	=	279	Hz),	124.5,	124.0,	113.6,	55.3	(q,	J	=	34	
Hz),	 54.8,	 36.4,	 35.8,	 34.6;	 IR	 (CCl4):	 νmax 1480,	 1366,	 1276,	 1263,	 1168,	 1132;	 HRMS	 (EI+):	
calculated	(found)	for	C12H1335ClF3NO2	:	327.0308	(327.0318).	
4.3.15 4-(2-Chloro-3,3,3-trifluoropropyl)-7-methyl-1,2,3,4-tetrahydro-1,8-naphthyridin-2-one	 (12b) 
Following	general	procedure	B	with	11b	 (830	mg,	2	mmol)	 in	chlorobenzene.	The	residue	was	
purified	by	silica	gel	column	chromatography	(petroleum	ether/ethyl	acetate	80:20	to	50:50)	to	
afford	 the	product	12b	 (250	mg,	43%)	as	 a	mixture	of	 two	diastereoisomers	60:40	and	as	 an	
amorphous	white	solid.	1H	NMR	(400	MHz;	CDCl3):	δH	9.97	(bs,	0.4H),	9.95	(bs,	0.6H),	7.47	(d,	J	=	
7.6	Hz,	0.6H),	7.41	(d,	J	=	7.6	Hz,	0.4H),	6.94	(d,	J	=	7.6	Hz,	1H),	4.26	(dqd,	J	=	12.3,	6.2,	3.6	Hz,	
0.4H),	3.74	(dqd,	J	=	12.5,	6.3,	2.4	Hz,	0.6H),	3.38-3.28	(m,	1H),	2.90	(dd,	J	=	16.5,	6.4	Hz,	0.6H),	
2.79	(dd,	 J	=	16.5,	6.9	Hz,	0.4H),	2.61-2.54	(m,	1H),	2.53	(s,	1.8H),	2.52	(s,	1.2H),	2.25-2.12	(m,	
1H),	2.05	(ddd,	J	=	14.9,	11.3,	4.6	Hz,	0.4H),	1.94	(ddd,	J	=	14.9,	11.3,	4.6	Hz,	0.6H);	13C	NMR	(100	
MHz;	CDCl3):	δC	major	diastereoisomer:	170.4,	157.7,	149.7,	136.7,	123.7	(q,	J	=	279	Hz),	118.3,	
115.3,	 55.5	 (q,	 J	 =	 33	Hz),	 36.7,	 34.2,	 31.1,	 23.5;	minor	 diastereoisomer:	 169.7,	 157.7,	 149.7,	
136.7,	123.8	(q,	J	=	279	Hz),	118.5,	117.4,	54.4	(q,	J	=	33	Hz),	34.4,	34.0,	31.0,	23.4;	IR	(CCl4):	νmax 
3406,	 2929,	 1711,	 1455,	 1268,	 1131;	 HRMS	 (EI+):	 calculated	 (found)	 for	 C12H1235ClF3N2O:	
292.0590	(292.0603).	
4.3.16 4-(2-Chloro-3,3,3-trifluoropropyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-one	 (12c) 
Following	general	procedure	B	with	11c	(500	mg,	1.13	mmol)	in	chlorobenzene.	The	residue	was	
purified	by	 silica	 gel	 column	chromatography	 (petroleum	ether/ethyl	 acetate	80:20)	 to	 afford	
the	 product	 12c	 (190	 mg,	 51%)	 as	 a	 mixture	 of	 two	 diastereoisomers	 85:15	 and	 as	 an	
amorphous	white	solid.	Mp	=	98-102	°C.	1H	NMR	(400	MHz;	CDCl3):	δH	major	diastereoisomer:	
8.09	(d,	J	=	8.7	Hz,	1H),	6.92	(dd,	J	=	8.7,	2.5	Hz,	1H),	6.78	(d,	J	=	2.5	Hz,	1H),	3.99	(dd,	J	=	12.7,	
4.1	Hz,	1H),	3.92-3.80	(m,	4H),	3.24	(dd,	J	=	12.7,	1.6	Hz,	1H),	3.20-3.15	(m,	1H),	3.15	(s,	3H),	2.39	
(ddd,	J	=	13.8,	11.3,	2.4	Hz,	1H),	2.03	(ddd,	J	=	14.2,	12.1,	3.9	Hz,	1H);	13C	NMR	(100	MHz;	CDCl3):	
δC	major	diastereoisomer:	164.0,	162.2,	140.3,	131.3,	123.9	(q,	J	=	279	Hz),	121.3,	113.0,	112.3,	
56.1	 (q,	 J	 =	 33	Hz),	 55.5,	 53.6,	 35.4,	 34.9,	 34.2;	 IR	 (CCl4):	 νmax 2930,	 1662,	 1609,	 1325,	 1260,	
1170,	1131;	HRMS	(EI+):	calculated	(found)	for	C14H1535ClF3NO2	:	321.0743	(321.0750).	
4.3.17 1-[3-(2-Chloro-3,3,3-trifluoropropyl)-6-fluoro-1H,2H,3H-pyrrolo[2,3-b]pyridin-1-yl]ethan-1-one
	 (12d) 
Following	general	procedure	B	with	11d	(3.45	mg,	7.7	mmol)	in	chlorobenzene.	The	residue	was	
purified	by	silica	gel	column	chromatography	(DCM)	and	recrystallized	from	an	EP/Et2O	mixture	
to	afford	the	product	12d	(895	mg,	36%)	as	a	mixture	of	two	diastereoisomers	55:45	and	as	an	
amorphous	white	solid.	Mp	=	120	°C.	1H	NMR	(400	MHz;	CDCl3):	δH	major	diastereoisomer:	7.67-
7.58	(m,	1H),	6.58	(dd,	8.0,	1.9	Hz,	1H),	4.36-4.26	(m,	1H),	4.27-4.15	(m,	1H),	4.02	(dd,	J	=	12.4,	
4.0	Hz,	1H),	3.58-3.48	(m,	1H),	2.68	(s,	3H),	3.32-2.13	(m,	2H);	minor	diastereoisomer:	7.67-7.58	
(m,	1H),	6.58	(dd,	8.0,	1.9	Hz,	1H),	4.36-4.26	(m,	1H),	4.27-4.15	(m,	1H),	3.86	(dd,	J	=	12.2,	5.9	Hz,	
1H),	 3.69-3.58	 (m,	 1H),	 2.68	 (s,	 3H),	 3.32-2.13	 (m,	 2H);	 13C	 NMR	 (100	MHz;	 CDCl3):	 δC	major	
diastereoisomer:	169.8,	163.0	(d,	J	=	239	Hz),	154.0	(d,	J	=	17	Hz),	137.2	(d,	J	=	9	Hz),	123.8	(q,	J	=	
279	Hz),	123.3	(d,	J	=	5	Hz),	101.9	(d,	J	=	37	Hz),	55.1	(q,	J	=	33	Hz),	53.0,	36.3,	32.5,	24.9;	minor	
diastereoisomer:	169.8,	163.0	(d,	J	=	239	Hz),	153.8	(d,	J	=	17	Hz),	136.9	(d,	J	=	9	Hz),	123.8	(q,	J	=	
279	Hz),	123.9	 (d,	 J	=	5	Hz),	102.1	 (d,	 J	=	37	Hz),	54.9	 (q,	 J	=	33	Hz),	51.0,	36.6,	32.1,	24.8;	 IR	
(CCl4):	νmax 2928,	1681,	1605,	1483,	1386,	1297,	1262,	1132;	HRMS	(EI+):	calculated	(found)	for	
C12H1135ClF4N2O	:	310.0496	(310.0497).	
4.3.18 1-[4-(2-Chloro-3,3,3-trifluoropropyl)-7-fluoro-1,2,3,4-tetrahydro-1,8-naphthyridin-1-yl]ethan-1-one
	 (12e) 
Following	general	procedure	B	with	11e	(500	mg,	1.15	mmol)	in	chlorobenzene.	The	residue	was	
purified	by	silica	gel	column	chromatography	(petroleum	ether/diethyl	ether	80:20	to	50:50)	to	
afford	 the	 product	 12e	 (187	mg,	 50%)	 as	 a	mixture	 of	 two	 diastereoisomers	 60:40	 and	 as	 a	
colorless	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	7.69-7.53	(m,	1H),	6.70-6.62	(m,	1H),	4.20	(dqd,	 J	=	
12.6,	 6.3,	 2.8	Hz,	 0.6H),	 4.06-3.71	 (m,	 2.4H),	 3.34-3.16	 (m,	 1H),	 2.56	 (s,	 1.8H),	 2.55	 (s,	 1.2H),	
2.26-1.93	(m,	3.4H),	1.77-1.67	(m,	0.6H);	13C	NMR	(100	MHz;	CDCl3):	δC	major	diastereoisomer:	
171.3,	160.1	(d,	J	=	239	Hz),	149.3	(d,	J	=	15	Hz),	141.4	(d,	J	=	8	Hz),	123.9	(q,	J	=	279	Hz),	122.3	
(d,	 J	 =	 5	 Hz),	 104.3	 (d,	 J	 =	 37	 Hz),	 55.0	 (q,	 J	 =	 33	 Hz),	 40.1,	 36.1,	 32.0,	 26.1,	 26.0;	 minor	
diastereoisomer:	171.7,	160.8	(d,	J	=	239	Hz),	149.1	(d,	J	=	15	Hz),	141.3	(d,	J	=	8	Hz),	123.9	(q,	J	=	
279	Hz),	121.6	(d,	J	=	5	Hz),	103.9	(d,	J	=	37	Hz),	55.8	(q,	J	=	33	Hz),	40.7,	34.3,	32.7,	27.5,	26.2;	IR	
(CCl4):	νmax 2934,	1682,	1585,	1465,	1435,	1370,	1274,	1131;	HRMS	(EI+):	calculated	(found)	for	
C13H1335ClF4N2O2	:	324.0653	(not	found).	
4.3.19 6,8-Dichloro-4-(2-chloro-3,3,3-trifluoropropyl)-1,2,3,4-tetrahydroquinolin-2-one	 (12f) 
Following	general	procedure	B	with	11f	(830	mg,	1.77	mmol)	in	chlorobenzene.	The	residue	was	
purified	by	silica	gel	column	chromatography	(petroleum	ether/diethyl	ether	80:20	to	50:50)	to	
afford	 the	 product	12f	 (282	mg,	 46%)	 as	 a	mixture	 of	 two	 diastereoisomers	 65:35	 and	 as	 an	
amorphous	white	 solid.	Mp	 =	 192°C.	 1H	 NMR	 (400	MHz;	 CDCl3):	 δH	 9.87	 (bs,	 0.35H),	 9.81	 (s,	
0.65H),	7.13	(d,	J	=	2.0	Hz,	0.65H),	7.12	(d,	J	=	2.0	Hz,	0.35H),	6.88	(d,	J	=	2.0	Hz,	0.65H),	6.86	(d,	J	
=	2.0	Hz,	0.35H),	4.33-4.23	(m,	0.35H),	4.16-4.04	(m,	0.65H),	3.85-3.78	(m,	0.35H),	3.78-3.72	(m,	
0.65H),	2.87-2.64	(m,	2H),	2.27	(ddd,	J	=	14.7,	8.6,	3.0	Hz,	0.7H),	2.13-1.96	(m,	1.3H);	13C	NMR	
(100	MHz;	CDCl3):	δC	major	diastereoisomer:	170.9,	138.9,	134.6,	133.9,	124.3,	123.7	(q,	J	=	279	
Hz),	 122.3,	 115.5,	 55.3	 (q,	 J	 =	 34	 Hz),	 36.2,	 35.8,	 30.2;	 minor	 diastereoisomer:	 170.2,	 138.7,	
134.5,	133.9,	124.3,	123.8	(q,	J	=	279	Hz),	122.1,	115.0,	54.3	(q,	J	=	34	Hz),	32.7,	31.9,	29.8;	 IR	
(CCl4):	νmax 3409,	1716,	1693,	1600,	1575,	1260,	1174,	1129;	HRMS	(EI+):	calculated	(found)	for	
C12H935Cl3F3NO	:	344.9702	(344.9711).	
4.3.20 4-(2-Chloro-3,3,3-trifluoropropyl)-6-methoxy-1,2,3,4-tetrahydronaphthalen-1-one	 (12g) 
Following	 general	 procedure	 B	 with	 11g	 (850	mg,	 2mmol)	 in	 ethyl	 acetate.	 The	 residue	 was	
purified	by	 silica	 gel	 column	chromatography	 (petroleum	ether/ethyl	 acetate	90:10)	 to	 afford	
the	 product	 12g	 (390	 mg,	 64%)	 as	 a	 mixture	 of	 two	 diastereoisomers	 85:15	 and	 as	 an	
amorphous	white	solid.	1H	NMR	(400	MHz;	CDCl3):	δH	8.03	(d,	J	=	8.7	Hz,	1H),	6.87	(dd,	J	=	8.7,	
2.4	Hz,	1H),	6.78	(d,	J	=	2.4	Hz,	1H),	4.01	(dqd,	J	=	12.8,	6.5,	2.7	Hz,	1H),	3.86	(s,	3H),	3.31-3.22	
(m,	1H),	2.73-2.56	(m,	2H),	2.46-2.25	(m,	2H),	2.13-2.00	(m,	2H);	13C	NMR	(100	MHz;	CDCl3):	δC	
195.6,	163.6,	146.9,	130.8,	125.3,	124.0	(q,	 J	=	279	Hz),	133.3,	112.9,	56.1	(q,	 J	=	33	Hz),	55.4,	
35.8,	34.1,	33.6,	28.2;	IR	(CCl4):	νmax 2929,	1685,	1599,	1269,	1256,	1129;	HRMS	(EI+):	calculated	
(found)	for	C14H1435ClF3O2	:	306.0634	(306.0638).	
4.3.21 Dimethyl	(4-chloro-5,5,5-trifluoropentyl)phosphonate	 (13a) 
A	magnetically	 round	 bottom	 flask	 was	 charged	with	 11h	 (300	mg,	 0.77	mmol),	 an	 aqueous	
solution	of	hypophosphorous	acid	(50%	wt)	(504	mg,	3.85	mmol),	triethylamine	(429	mg,	4.25	
mmol),	7.6	mL	of	dioxane.	The	solution	was	refluxed	under	a	flow	of	nitrogen	for	5	minutes	then	
AIBN	 (13	 mg,	 0.08	 mmol)	 was	 added	 every	 hour	 until	 TLC	 showed	 total	 conversion	 of	 the	
starting	xanthate.	The	mixture	was	cooled	to	room	temperature	and	ethyl	acetate	was	added.	
The	 layers	were	partitioned	and	the	aqueous	one	was	extracted	twice	with	ethyl	acetate.	The	
combined	organic	layers	were	washed	with	brine	and	dried	over	anhydrous	MgSO4.	The	residue	
was	purified	by	silica	gel	column	chromatography	(DCM/methanol	95:5)	to	afford	the	product	
13a	(188	mg,	93%)	as	an	orange	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	4.06	(dqd,	J	=	9.8,	6.6,	3.2	Hz,	
1H),	3.74	(s,	3H),	3.71	(s,	3H),	2.14-1.68	(m,	6H);	13C	NMR	(100	MHz;	CDCl3):	δC	124.0	(q,	J	=	279	
Hz),	56.9	(q,	J	=	33	Hz),	52.4	(d,	J	=	7	Hz),	52.4	(d,	J	=	7	Hz),	31.4	(d,	J	=	15	Hz),	23.8	(d,	J	=	143	Hz),	
19.0	 (d,	 J	 =	 5	 Hz);	 IR	 (CCl4):	 νmax 3685,	 3453,	 2953,	 1267,	 1180,	 1126,	 1062;	 HRMS	 (EI+):	
calculated	(found)	for	C7H1335ClF3O3P	:	268.0243	(not	found).	
4.3.22 1-[(4-Chloro-5,5,5-trifluoropentyl)oxy]-4-methoxybenzene	 (13b) 
A	 magnetically	 round	 bottom	 flask	 was	 charged	 with	 11i	 (670	 mg,	 1.66	 mmol),	
tris(trimethylsilyl)silane	(496	mg,	2	mmol)	in	16	mL	of	a	1:1	solution	of	toluene	and	cyclohexane.	
The	solution	was	refluxed	under	a	flow	of	nitrogen	for	5	minutes	then	AIBN	(26mg,	0.16	mmol)	
was	 added.	 After	 30	 min,	 the	 mixture	 was	 cooled	 to	 room	 temperature	 and	 the	 solvent	
evaporated	 under	 reduced	 pressure.	 The	 residue	 was	 purified	 by	 silica	 gel	 column	
chromatography	(petroleum	ether/diethyl	ether	96:4)	to	afford	the	product	13b	(230	mg,	47%)	
as	a	colorless	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	6.84	(s,	4H),	4.25-4.14	(m,	1H),	4.03-3.91(m,	2H),	
3.77	(s,	3H),	2.33-2.22	(m,	1H),	2.17-2.05	(m,	1H),	2.03-1.88	(m,	2H);	13C	NMR	(100	MHz;	CDCl3):	
δC	154.0,	152.9,	124.14	(q,	J	=	279	Hz),	115.4	(2C),	114.7	(2C),	67.3,	57.4	(q,	J	=	33	Hz),	55.8,	28.1,	
25.6;	 IR	 (CCl4):	 νmax 2935,	 1508,	 1272,	 1231,	 1172,	 1131;	 HRMS	 (EI+):	 calculated	 (found)	 for	
C15H1835ClF3O2S2	:	282.0634	(282.0632).	
4.3.23 12-Chloro-13,13,13-trifluoro-N,N-diphenyltridecanamide	 (13c) 
A	 magnetically	 round	 bottom	 flask	 was	 charged	 with	 11j	 (803	 mg,	 1.4	 mmol),	 an	 aqueous	
solution	 of	 hypophosphorous	 acid	 (50%	wt)	 (924	mg,	 7.0	mmol),	 triethylamine	 (777	mg,	 7.7	
mmol)	 in	14	mL	of	dioxane.	The	solution	was	refluxed	under	a	 flow	of	nitrogen	for	5	minutes	
then	AIBN	(23	mg,	0.14	mmol)	was	added	every	hour	until	TLC	showed	total	conversion	of	the	
starting	xanthate.	The	mixture	was	cooled	to	room	temperature	and	ethyl	acetate	was	added.	
The	 layers	were	partitioned	and	the	aqueous	one	was	extracted	twice	with	ethyl	acetate.	The	
combined	organic	layers	were	washed	with	brine	and	dried	over	anhydrous	MgSO4.	The	residue	
was	 purified	 by	 silica	 gel	 column	 chromatography	 (petroleum	 ether/diethyl	 ether	 80:20)	 to	
afford	the	product	13c	(625	mg,	98%)	as	an	orange	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	7.46-7.32	
(m,	4H),	7.31-7.17	(m,	6H),	4.07	(dqd,	J	=	10.0,	6.7,	3.3	Hz,	1H),	2.27	(t,	J	=	7.5	Hz,	2H),	2.04-1.93	
(m,	1H),	1.86-1.72	(m,	1H),	1.72-1.58	(m,	3H),	1.49-1.19	(m,	13H);	13C	NMR	(100	MHz;	CDCl3):	δC	
173.2,	142.9	(2C),	130.4-125.3	(m,	10C),	124.1	(q,	J	=	280	Hz),	57.6	(q,	J	=	33	Hz),	35.2,	30.8,	29.3	
(3C),	29.1	(2C),	28.6,	25.5	(2C);	IR	(CCl4):	νmax 2928,	2856,	1680,	1493,	1371,	1269,	1178,	1129;	
HRMS	(EI+):	calculated	(found)	for	C25H3135ClF3NO	:	453.2046	(453.2035).	
4.3.24 3-(3,3-difluoroprop-2-en-1-yl)-1-methanesulfonyl-2,3-dihydro-1H-indole	 (14a) 
Following	general	procedure	C	with	12a	(80	mg,	0.24	mmol).	14a	(64	mg,	95%)	was	obtained	as	
a	white	solid	without	purification.	1H	NMR	(400	MHz;	CDCl3):	δH	7.45	(d,	 J	=	8.1	Hz,	1H),	7.33-
7.22	(m,	2H),	7.11	(td,	J	=	7.5,	0.9	Hz,	1H),	4.21	(dtd,	J	=	24.7,	8.0,	2.2	Hz,	1H),	4.10	(dd,	J	=	10.4,	
9.2	Hz,	1H),	3.69	 (dd,	 J	=	10.4,	5.9	Hz,	1H),	3.50-3.41	 (m,	1H),	2.93	 (s,	3H),	2.50-2.40	 (m,	1H),	
2.36-2.26	(m,	1H);	13C	NMR	(100	MHz;	CDCl3):	δC	157.1	(t,	J	=	288	Hz),	141.8,	133.3,	128.7,	124.6,	
123.7,	113.5,	74.7	(dd,	J	=	23,	20	Hz),	55.3,	39.7	(t,	J	=	2	Hz),	34.5,	27.3	(d,	J	=	4	Hz);	IR	(CCl4):	νmax 
1746,	 1480,	 1460,	 1364,	 1166;	 HRMS	 (EI+):	 calculated	 (found)	 for	 C12H13F2NO2	 :	 273.0635	
(273.0640).	
4.3.25 4-(3,3-Difluoroprop-2-en-1-yl)-7-methyl-1,2,3,4-tetrahydro-1,8-naphthyridin-2-one	 (14b) 
Following	 general	 procedure	 C	 with	 12b	 (50.0	 mg,	 0.17	 mmol).	 14b	 (40.4	 mg,	 100%)	 was	
obtained	as	a	colorless	oil	without	purification.	1H	NMR	(400	MHz;	CDCl3):	δH	8.51	(bs,	1H),	7.35	
(d,	J	=	7.6	Hz,	1H),	6.82	(d,	J	=	7.6	Hz,	1H),	4.12	(dtd,	J	=	24.5,	8.0,	2.0	Hz,	1H),	3.01-2.93	(m,	1H),	
2.77	(dd,	J	=	16.4,	6.3	Hz,	1H),	2.56	(dd,	J	=	16.4,	4.6	Hz,	1H),	2.48	(s,	3H),	2.33-2.20	(m,	2H);	13C	
NMR	(100	MHz;	CDCl3):	δC	170.1,	158.4	(t,	J	=	287	Hz),	156.6,	149.5,	136.12,	118.2,	117.4,	74.6	
(dd,	J	=	24,	21	Hz),	35.8,	34.9	(t,	J	=	2	Hz),	27.0	(d,	J	=	4	Hz),	23.6;	IR	(CCl4):	νmax 3408,	2927,	1745,	
1709,	1608,	1456,	1350,	1275,	1156;	HRMS	(EI+):	calculated	(found)	for	C12H12F2N2O	:	238.0918	
(238.0925).	
4.3.26 4-(3,3-Difluoroprop-2-en-1-yl)-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-one	 (14c) 
Following	general	procedure	C	with	12c	(95	mg,	0.29	mmol).	14c	(75.1	mg,	97%)	was	obtained	
as	a	pale	yellow	oil	without	purification.	1H	NMR	(400	MHz;	CDCl3):	δH	8.02	(d,	J	=	8.7	Hz,	1H),	
6.84	(dd,	J	=	8.7,	2.5	Hz,	1H),	6.63	(d,	J	=	2.5	Hz,	1H),	4.17	(dddd,	J	=	24.8,	9.3,	7.2,	2.2	Hz,	1H),	
3.82	(s,	3H),	3.73	(dd,	J	=	12.6,	4.4	Hz,	1H),	3.28	(dd,	J	=	12.6,	3.3	Hz,	1H),	3.10	(s,	3H),	2.84-2.76	
(m,	 1H),	 2.42-2.31	 (m,	 1H),	 2.30-2.19	 (m,	 1H);	 13C	NMR	 (100	MHz;	 CDCl3):	 δC	 164.25,	 162.21,	
157.0	(dd,	J	=	288,	287	Hz),	142.7,	130.5,	121.5,	112.5,	111.8,	75.4	(dd,	J	=	23,	21	Hz),	55.3,	51.3,	
37.9	 (t,	 J	=	2	Hz),	35.14,	26.5	 (d,	 J	=	4	Hz);	 IR	 (CCl4):	νmax 2930,	1745,	1660,	1608,	1485,	1259;	
HRMS	(EI+):	calculated	(found)	for	C14H15F2NO2	:	267.1071	(267.1069).	
4.3.27 6,8-Dichloro-4-(3,3-difluoroprop-2-en-1-yl)-1,2,3,4-tetrahydroquinolin-2-one	(14f) 
Following	general	procedure	C	with	12f	(130	mg,	0.38	mmol).	The	residue	was	purified	by	silica	
gel	column	chromatography	(petroleum	ether/diethyl	ether	70:30)	to	afford	14f	(55	mg,	50%)	as	
an	amorphous	white	solid.	Mp	:	136-138°C.	1H	NMR	(400	MHz;	CDCl3):	δH	9.65	(bs,	1H),	7.09	(d,	J	
=	2.0	Hz,	1H),	6.82	(d,	J	=	2.0	Hz,	1H),	4.18	(dtd,	J	=	24.5,	8.2,	2.1	Hz,	1H),	3.47-3.40	(m,	1H),	2.77-
2.64	 (m,	 2H),	 2.32-2.13	 (m,	 2H);	 13C	 NMR	 (100	MHz;	 CDCl3):	 δC	 171.0,	 155.8	 (q,	 J	 =	 288	 Hz),	
138.7,	134.1,	133.9,	124.0,	122.5,	114.9,	74.5	(dd,	J	=	23,	21	Hz),	34.2,	33.4,	25.7;	IR	(CCl4):	νmax 
2952,	 1745,	 1691,	 1601,	 1578,	 1394,	 1373,	 1317;	 HRMS	 (EI+):	 calculated	 (found)	 for	
C12H935Cl2F2NO	:	291.0029	(291.0024).	
4.3.28 3-(3,3-Difluoroprop-2-en-1-yl)-6-fluoro-1H,2H,3H-pyrrolo[2,3-b]pyridine	 (16a) 
Following	general	procedure	C	with	15a31(a)	 (110	mg,	0.41	mmol).	The	residue	was	purified	by	
silica	gel	column	chromatography	(petroleum	ether/diethyl	ether	70:30)	to	afford	16a	 (75	mg,	
88%)	as	a	colorless	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	7.30-7.22	(m,	1H),	6.07	(dd,	J	=	7.7,	1.0	Hz,	
1H),	4.67	(bs,	1H),	4.17	(dtd,	J	=	24.9,	8.0,	2.4	Hz,	1H),	3.82-3.72	(m,	1H),	3.40-3.29	(m,	2H),	2.41-
2.22	(m,	2H);	13C	NMR	(100	MHz;	CDCl3):	δC	163.9	(d,	J=	236	Hz),	163.1	(d,	J	=	18	Hz),	157.0	(dd,	J	
=	288,	287	Hz),	134.6	(d,	J	=	9	Hz),	120.1	(d,	J	=	5	Hz),	95.3	(d,	J	=	37	Hz),	75.0	(dd,	J	=	23,	21	Hz),	
50.3,	39.1	 (t,	 J	=	2	Hz),	27.2	 (d,	 J	=	4	Hz);	 13C	NMR	(100	MHz;	CDCl3):	δC	163.9	 (d,	 J=	236	Hz),	
163.1	(d,	J	=	18	Hz),	157.0	(dd,	J	=	288,	287	Hz),	134.6	(d,	J	=	9	Hz),	120.1	(d,	J	=	5	Hz),	95.3	(d,	J	=	
37	Hz),	75.0	 (dd,	 J	=	23,	21	Hz),	50.3,	39.1	 (t,	 J	=	2	Hz),	27.2	 (d,	 J	=	4	Hz);	 IR	 (CCl4):	νmax 3444,	
2927,	 1746,	 1620,	 1595,	 1445;	 HRMS	 (EI+):	 calculated	 (found)	 for	 C10H935ClF3N2	 :	 214.0718	
(214.0722).	
4.3.29 1-[4-(3,3-Difluoroprop-2-en-1-yl)-7-fluoro-1,2,3,4-tetrahydro-1,8-naphthyridin-1-yl]ethan-1-one
	 (16b) 
Following	general	procedure	C	with	15b31(b)	(52	mg,	0.18	mmol).	16b	(35	mg,	83%)	was	obtained	
as	an	amorphous	white	solid	without	purification.	Mp	=	64-66	°C.	1H	NMR	(400	MHz;	CDCl3):	δH	
7.25	(t,	J	=	8.0	Hz,	1H),	6.06	(dd,	J	=	7.9,	2.4	Hz,	1H),	5.29	(bs,	1H),	4.18	(dddd,	J	=	25.1,	8.6,	7.5,	
2.4	Hz,	1H),	3.44-3.37	(m,	2H),	2.80-2.73	(m,	1H),	2.33-	2.15	(m,	2H),	1.94-	1.84	(m,	1H),	1.83-	
1.74	(m,	1H);	13C	NMR	(100	MHz;	CDCl3):	δC	162.0	(d,	 J	=	235	Hz),	156.9	(dd,	 J	=	287,	288	Hz),	
154.3	(d,	J	=	17	Hz),	140.0	(d,	J	=	9	Hz),	114.2	(d,	J	=	4	Hz),	95.0	(d,	J	=	37	Hz),	75.5	(dd,	J	=	23,	21	
Hz),	37.7,	34.8,	28.1	(d,	J	=	4	Hz),	25.0;	IR	(CCl4):	νmax 3447,	3272,	2931,	1745,	1618,	1462,	1355,	
1224;	HRMS	(EI+):	calculated	(found)	for	C11H11F3N2	:	228.0874	(228.0881).	
4.3.30 Dimethyl	(5,5-difluoropent-4-en-1-yl)phosphonate	(14h) 
Following	general	procedure	C	with	13a	(150	mg,	0.57	mmol).	The	residue	was	purified	by	silica	
gel	column	chromatography	(DCM/methanol	95:5)	to	afford	14h	(98	mg,	80%)	as	a	colorless	oil.	
1H	NMR	(400	MHz;	CDCl3):	δH	4.10	(dtd,	J	=	25.2,	7.9,	2.4	Hz,	1H),	3.73	(s,	3H),	3.70	(s,	3H),	2.13-
1.98	(m,	2H),	1.79-1.59	(m,	4H);	13C	NMR	(100	MHz;	CDCl3):	δC	156.6	(t,	 J	=	287	Hz),	76.9-76.3	
(m),	52.3	(d,	J	=	6	Hz,	2C),	23.9	(d,	J	=	142	Hz),	22.9	(dd,	J	=	18,	4	Hz),	22.2;	IR	(CCl4):	νmax 2953,	
1747,	1248,	1064,	1036;	HRMS	(EI+):	calculated	(found)	for	C7H13F2O3P:	214.0570	(214.0567).	
4.3.31 1-[(5,5-Difluoropent-4-en-1-yl)oxy]-4-methoxybenzene	 (14i) 
Following	general	procedure	C	with	13b	(210	mg,	0.74	mmol).	The	residue	was	purified	by	silica	
gel	column	chromatography	(petroleum	ether/diethyl	ether	97:3)	to	afford	the	product	14i	(153	
mg,	90%)	as	a	colorless	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	6.83	(s,	4H),	4.19	(dtd,	J	=	25.3,	7.9,	2.5	
Hz,	1H),	3.92	(t,	J	=	6.2	Hz,	2H),	3.77	(s,	3H),	2.21-2.13	(m,	2H),	1.84	(m,	2H);	13C	NMR	(100	MHz;	
CDCl3):	δC	156.4	(dd,	J	=	287,	285	Hz),	153.9,	153.1,	115.5	(2C),	114.7	(2C),	77.5-77.0	(m),	67.6,	
55.8,	 29.1	 (t,	 J	 =	 2	Hz),	 19.0	 (d,	 J	 =	 4	Hz);	 IR	 (CCl4):	νmax 2951,	 1746,	 1509,	 1231;	HRMS	 (EI+):	
calculated	(found)	for	C15H1835ClF3O2S2	:	228.0962	(228.0964).	
4.3.32 13,13-Difluoro-N,N-diphenyltridec-12-enamide	 (14j) 
Following	general	procedure	C	with	13c	(225	mg,	0.5	mmol).	The	residue	was	purified	by	silica	
gel	 column	 chromatography	 (petroleum	 ether/diethyl	 ether	 80:20)	 to	 afford	 the	 product	 14j	
(100	mg,	50%)	as	a	colorless	oil.	1H	NMR	(400	MHz;	CDCl3):	δH	7.47-7.31	(m,	4H),	7.31-7.19	(m,	
6H),	4.13	(dtd,	J	=	25.6,	7.9,	2.7	Hz,	1H),	2.27	(t,	J	=	7.5	Hz,	2H),	2.00-1.93	(m,	2H),	1.66	(q,	J	=	7.2	
Hz,	2H),	1.40-1.19	 (m,	14H);	 13C	NMR	 (100	MHz;	CDCl3):	δC	173.2,	156.1	 (t,	 J	=	285	Hz),	142.9	
(2C),	131.5-123.7	(10C),	78.0	(t,	J	=	21	Hz),	35.2,	29.4,	29.3	(2C),	29.2	(2C),	28.8,	25.5,	22.1	(2C);	
IR	 (CCl4):	νmax 2928,	2856,	1746,	1680,	1594,	1493,	1369,	1271;	HRMS	(EI+):	calculated	(found)	
for	C25H31F2NO	:	399.2374	(399.2371).	
4.3.33 2-(5-Chloro-6,6,6-trifluorohex-2-en-2-yl)-5,5-dimethyl-1,3-dioxane	 (18) 
A	magnetically	stirred	round	bottom	flask	was	charged	with	17	(205	mg,	0.73	mmol),	xanthate	1	
(260.0	mg,	1.09	mmol),	ethyl	acetate	(1.1	mL)	and	the	solution	was	heated	to	reflux.	DLP	(58mg,	
0.14	mmol)	was	then	added	by	portion	every	hour	until	total	consumption	of	the	starting	olefin	
was	 observed.	 The	 crude	 mixture	 was	 passed	 through	 a	 pad	 of	 basic	 Al2O3,	 the	 solvent	
evaporated	 and	 the	 residue	 was	 purified	 on	 flash	 column	 chromatography	 (petroleum	
ether/ethyl	acetate	95:5)	to	afford	compound	18	(158	mg,	75%)	as	two	isomers	in	a	3.5:1	ratio.	
1H	NMR	(400	MHz;	CDCl3):	δH	major	isomer:	5.68	(t,	J	=	6.8	Hz,	1H),	4.74	(s,	1H),	4.14-4.04	(m,	
1H),	3.66	(d,	J	=	11.2	Hz,	2H),	3.50	(d,	J	=	10.8	Hz,	2H)	2.79	(ddd,	J	=	15.6,	6.8,	3.6	Hz,	1H),	2.58	
(ddd,	J	=	15.6,	9.6,	7.2	Hz,	1H),	2.10	(s,	3H),	1.76	(s,	3H),	1.22	(s,	3H),	0.74	(s,	3H);	minor	isomer:	
5.45	(t,	J	=	7.2	Hz,	1H),	5.05	(s,	1H),	4.16-4.05	(m,	1H),	3.69-3.62	(m,	2H),	3.50	(d,	J	=11.2	Hz,	2H),	
2.91	(dddd,	J	=	15.2	Hz,	7.6,	3.6,	1.2	Hz,	1H),	2.57	(dddd,	J	=	15.2,	10.0,	7.6	1.2	Hz,	1H),	1.85	(d,	J	
=	 1.2	Hz,	 3H),	 1.22	 (s,	 3H,),	 0.75	 (s,	 3H,);	 13C	NMR	 (100	MHz;	CDCl3):	 δC	major	 isomer:	 137.6,	
124.0	(q,	J	=277	Hz),	121.7,	104.1,	77.2	(2C),	56.9	(q,	J	=33	Hz),	30.1,	29.5,	22.9,	21.8,	11.7;	minor	
isomer:	137.8,	124.0	 (q,	 J	=277	Hz),	122.5,	99.4,	77.3	 (2C),	57.4	 (q,	 J	=32	Hz),	30.1,	29.5,	22.9,	
21.9,	18.6;	 IR	 (CCl4):	νmax major	 isomer:	2958,	2848,	1469,	1394,	1261,	1185,	1128,	1016,	983;	
minor	isomer:	2959,	2851,	1470,	1395,	1365,	1262,	1183,	1127,	1016,	983;		
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